Studies suggest that monoterpenes might offer new chemotherapy strategies for cancer and inflammatory diseases [8,9,10,11], and accumulating evidence in the last decades has indicated that GNL is a pure botanical compound without adverse effects, exerting diverse pharmacological activities by mainly regulating protein expression. This evidence concerns the gene RGN and cancer.